SUBSCRIBE
SUBSCRIBE
News   Deals

Light Sciences Oncology, Inc. Withdraws IPO Plans; Cites Market Conditions

February 11, 2008 | 
1 min read

Feb 8 (Reuters) - Light Sciences Oncology Inc on Friday filed with the U.S. Securities and Exchange Commission to withdraw its initial public offering, citing unfavorable market conditions.

IPO
MORE ON THIS TOPIC
Pictured: Entrance to the FTC's office in Washington, DC
Editorial
Pressure Mounts on Novo’s $16.5B Catalent Buy Amid FTC Review
October 11, 2024
 · 
3 min read
 · 
Greg Slabodkin
Art collage, coins, and arrow up on the red and paper background. Concept of business and financial growth.
IPO
Upstream Raises $255M IPO for Inflammatory Drugs; CAMP4 Nets $75M for RNA Work
October 11, 2024
 · 
1 min read
 · 
Annalee Armstrong
Man inside a boat made with a dollar
M&A
Concentra Spies New Target After Kezar’s Lupus Trial Hold
October 9, 2024
 · 
1 min read
 · 
Kate Goodwin
South San Francisco, CA, USA - May 1, 2022: Exterior view of the Merck Researches Laboratories in South San Francisco, California. Merck & Co., Inc. is a global pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme (MSD) outside the United States and Canada.
Drug Development
Keytruda Redeems Itself in Head and Neck Cancer as Merck Lands Potential $1.9B I&I Collab
October 8, 2024
 · 
2 min read
 · 
Kate Goodwin